Emel Aygören-Pürsün

Summary

Affiliation: Frankfurt am Main
Country: Germany

Publications

  1. ncbi HAE international home therapy consensus document
    Hilary J Longhurst
    Department of Immunology, Barts and The London NHS Trust, London, UK
    Allergy Asthma Clin Immunol 6:22. 2010
  2. ncbi 2010 International consensus algorithm for the diagnosis, therapy and management of hereditary angioedema
    Tom Bowen
    Departments of Medicine and Paediatrics, University of Calgary, Calgary, Alberta, Canada
    Allergy Asthma Clin Immunol 6:24. 2010
  3. ncbi Retrochorionic hematoma in congenital afibrinogenemia: resolution with fibrinogen concentrate infusions
    E Aygören-Pürsün
    Department of Pediatric Hematology, Oncology and Hemostasis, Johann Wolfgang Goethe University Hospital, Frankfurt am Main, Germany
    Am J Hematol 82:317-20. 2007
  4. ncbi On demand treatment and home therapy of hereditary angioedema in Germany - the Frankfurt experience
    Emel Aygören-Pürsün
    Centre of Pediatrics III, Department of Hematology, Oncology and Hemostasis, Comprehensive Care Centre for Thrombosis and Hemostasis, Johann Wolfgang Goethe University Hospital, Frankfurt am Main, Germany
    Allergy Asthma Clin Immunol 6:21. 2010
  5. ncbi Characterization of acute hereditary angioedema attacks during pregnancy and breast-feeding and their treatment with C1 inhibitor concentrate
    Inmaculada Martinez-Saguer
    Department of Hematology, Center of Pediatrics III, Johann Wolfgang Goethe University Hospital, Frankfurt am Main, Germany
    Am J Obstet Gynecol 203:131.e1-7. 2010
  6. ncbi Home therapy with intravenous human C1-inhibitor in children and adolescents with hereditary angioedema
    Wolfhart Kreuz
    Johann Wolfgang Goethe University Hospital, Frankfurt am Main, Germany
    Transfusion 52:100-7. 2012
  7. ncbi Pharmacokinetic analysis of human plasma-derived pasteurized C1-inhibitor concentrate in adults and children with hereditary angioedema: a prospective study
    Inmaculada Martinez-Saguer
    Centre of Paediatrics III, Department of Haematology, Oncology and Haemostasis, Comprehensive Care Centre for Thrombosis and Haemostasis, Johann Wolfgang Goethe University Hospital, Frankfurt am Main, Germany
    Transfusion 50:354-60. 2010
  8. ncbi C1-inhibitor concentrate for individual replacement therapy in patients with severe hereditary angioedema refractory to danazol prophylaxis
    Wolfhart Kreuz
    Department of Haematology, Johann Wolfgang Goethe University Hospital, Centre of Paediatrics III, Frankfurt am Main, Germany
    Transfusion 49:1987-95. 2009

Collaborators

  • Inmaculada Martinez-Saguer
  • Wolfhart Kreuz
  • J Oldenburg
  • Tom Bowen
  • Hilary J Longhurst
  • Konrad Bork
  • Anette Bygum
  • Teresa Caballero
  • Henriette Farkas
  • Timothy Craig
  • Avner Reshef
  • Janne Bjorkander
  • Bruce Zuraw
  • Laurence Bouillet
  • Marco Cicardi
  • Della Cogar
  • Emel Aygoeren-Pürsün
  • Marcel Levi
  • Gina Lacuesta
  • Doris Neurath
  • Georges Etienne Rivard
  • Smeeksha Sur
  • Eva Rusicke
  • Janet Long
  • John Brosz
  • Susan Waserman
  • Richard Warrington
  • Amin Kanani
  • George Fust
  • Donald Stark
  • Eric Leith
  • Lilian Varga
  • Dereth Rowan
  • Karen Binkley
  • Bruce Ritchie
  • John Dean
  • Ursula Huffer
  • Azza Hamed
  • Jimmy Gooi
  • Claire Bethune
  • Rohan Ameratunga
  • John Dempster
  • Sean Mace
  • Henrik Boysen
  • George Harmat
  • Istvan Nagy
  • Erik W Nielsen
  • Ellie Tsai
  • Robert Schellenberg
  • Man Chiu Poon
  • Palinder Kamra
  • Patrik Nordenfelt
  • Michel Raguet
  • Ramachand Devaraj
  • Henry Li
  • Sarah Smith-Foltz
  • Zhi Yu Xiang
  • Harriet Lyons
  • Stephen Betschel
  • Sofia Grigoriadou
  • Jacques Hebert
  • Mark Gompels
  • Peter Späth
  • Dumitru Moldovan
  • Anne Rowe
  • Barbara Mako
  • Kristylea Brosz
  • Paul K Keith
  • Marcel M Levi
  • Mike Frank
  • Jonathan Bernstein

Detail Information

Publications8

  1. ncbi HAE international home therapy consensus document
    Hilary J Longhurst
    Department of Immunology, Barts and The London NHS Trust, London, UK
    Allergy Asthma Clin Immunol 6:22. 2010
    ..It represents the opinion of the authors who have a wide range of expert experience in the management of HAE...
  2. ncbi 2010 International consensus algorithm for the diagnosis, therapy and management of hereditary angioedema
    Tom Bowen
    Departments of Medicine and Paediatrics, University of Calgary, Calgary, Alberta, Canada
    Allergy Asthma Clin Immunol 6:24. 2010
    ....
  3. ncbi Retrochorionic hematoma in congenital afibrinogenemia: resolution with fibrinogen concentrate infusions
    E Aygören-Pürsün
    Department of Pediatric Hematology, Oncology and Hemostasis, Johann Wolfgang Goethe University Hospital, Frankfurt am Main, Germany
    Am J Hematol 82:317-20. 2007
    ..Median fibrinogen levels under 60 mg/dL may be adequate to maintain pregnancy in patients with congenital afibrinogenemia, although it is possible that higher levels might reduce the risk of hemorrhagic events...
  4. ncbi On demand treatment and home therapy of hereditary angioedema in Germany - the Frankfurt experience
    Emel Aygören-Pürsün
    Centre of Pediatrics III, Department of Hematology, Oncology and Hemostasis, Comprehensive Care Centre for Thrombosis and Hemostasis, Johann Wolfgang Goethe University Hospital, Frankfurt am Main, Germany
    Allergy Asthma Clin Immunol 6:21. 2010
    ..Manifestation of acute edema in hereditary angioedema (HAE) is characterized by interindividual and intraindividual variability in symptom expression over time. Flexible therapy options are needed...
  5. ncbi Characterization of acute hereditary angioedema attacks during pregnancy and breast-feeding and their treatment with C1 inhibitor concentrate
    Inmaculada Martinez-Saguer
    Department of Hematology, Center of Pediatrics III, Johann Wolfgang Goethe University Hospital, Frankfurt am Main, Germany
    Am J Obstet Gynecol 203:131.e1-7. 2010
    ....
  6. ncbi Home therapy with intravenous human C1-inhibitor in children and adolescents with hereditary angioedema
    Wolfhart Kreuz
    Johann Wolfgang Goethe University Hospital, Frankfurt am Main, Germany
    Transfusion 52:100-7. 2012
    ..C1-esterase inhibitor (C1-INH) replacement therapy is the treatment of choice for acute edema attacks in patients with hereditary angioedema (HAE)...
  7. ncbi Pharmacokinetic analysis of human plasma-derived pasteurized C1-inhibitor concentrate in adults and children with hereditary angioedema: a prospective study
    Inmaculada Martinez-Saguer
    Centre of Paediatrics III, Department of Haematology, Oncology and Haemostasis, Comprehensive Care Centre for Thrombosis and Haemostasis, Johann Wolfgang Goethe University Hospital, Frankfurt am Main, Germany
    Transfusion 50:354-60. 2010
    ..This pharmacokinetic study was conducted to investigate the pharmacokinetics of pasteurized human plasma-derived C1-INH concentrate (pC1-INH)...
  8. ncbi C1-inhibitor concentrate for individual replacement therapy in patients with severe hereditary angioedema refractory to danazol prophylaxis
    Wolfhart Kreuz
    Department of Haematology, Johann Wolfgang Goethe University Hospital, Centre of Paediatrics III, Frankfurt am Main, Germany
    Transfusion 49:1987-95. 2009
    ....